Demant A/S (CPH:DEMANT)
263.80
+5.00 (1.93%)
Mar 3, 2025, 4:59 PM CET
Demant Revenue
In the year 2024, Demant had annual revenue of 22.42B DKK with 3.79% growth. Demant had revenue of 11.33B in the half year ending December 31, 2024, with 11.01% growth.
Revenue
22.42B
Revenue Growth
+3.79%
P/S Ratio
2.56
Revenue / Employee
1.05M
Employees
22,639
Market Cap
56.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.42B | 818.00M | 3.79% |
Dec 31, 2023 | 21.60B | 1.90B | 9.62% |
Dec 31, 2022 | 19.71B | 1.80B | 10.05% |
Dec 31, 2021 | 17.91B | 3.44B | 23.75% |
Dec 31, 2020 | 14.47B | -477.00M | -3.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 290.40B |
Coloplast | 27.45B |
Genmab | 21.53B |
Zealand Pharma | 62.69M |
H. Lundbeck | 22.00B |
Ambu A/S | 5.65B |
ALK-Abelló | 5.54B |
GN Store Nord | 17.99B |